The problem which loomed behind the stated barriers is that continuing with the historical mode of investment will simply not deliver the stated intent and aspirations of the industry and society at large..

Laboratories play a key part in this transformation, supporting all stages of the life science value-chain: including R&D, quality control, diagnostic services, and teaching.As a result, demand for labs is growing rapidly.

In Cambridge and Oxford for example (two of the UK’s main life science hubs), demand for labs now outstrips available supply by nearly a hundred to one.Alongside this growth, improvements in IT, staffing challenges, and new ways of working, now mean that remote or flexible working is commonplace.For life science developers and companies this has created a major opportunity: converting increasingly vacant or cheaper office space into labs – saving time and money.

This may appear to be the perfect solution, however there are additional challenges to consider..Conversion of an existing office tenancy into a new PCR and bloodwork lab.. 1.

Space.. Spatial constraints in office buildings can result in unproductive or inflexible lab layouts.. Office to lab conversions will often result in some compromises.

Where the science, technology, and compliance (safety and quality) are generally hard requirements, it is often the productivity or flexibility of the lab space that is impacted..Text extracts are taken from IPA’s ‘.

Transforming Infrastructure Performance: Roadmap to 2030.P-DfMA addresses numerous value drivers, the diagram below summarises some of the key aspects of the Building Safety Act, and how a platform approach aligns across the whole project lifecycle..

Learn more about a Platform Approach to Design for Manufacture and Assembly (P-DfMA) on our.share their insights and visions for a more efficient and innovative future in construction.. Click the 'play button' above to listen in, or read our 5 Key Takeaways from this episode below.... 1.Embracing lean construction:.